Morgia, G., Reale, G., Vespasiani, G., Di Mauro, M., Pareo, R. M., Voce, S., . . . Russo, G. I. (2017). MP09-04 COMPARISON BETWEEN TADALAFIL 5 MG VS. SERENOA REPENS/SELENIUM/LYCOPENE FOR THE TREATMENT OF BENIGN PROSTATIC LOWER URINARY TRACT SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA. A PHASE IV, RANDOMIZED, MULTICENTER, NON-INFERIORITY CLINICAL STUDY. SPRITE STUDY. Journal of urology, 197(4), e100.

Morgia, Giuseppe, et al. "MP09-04 COMPARISON BETWEEN TADALAFIL 5 MG VS. SERENOA REPENS/SELENIUM/LYCOPENE FOR THE TREATMENT OF BENIGN PROSTATIC LOWER URINARY TRACT SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA. A PHASE IV, RANDOMIZED, MULTICENTER, NON-INFERIORITY CLINICAL STUDY. SPRITE STUDY." Journal of Urology 197, no. 4 (2017): e100.

Morgia, Giuseppe, et al. "MP09-04 COMPARISON BETWEEN TADALAFIL 5 MG VS. SERENOA REPENS/SELENIUM/LYCOPENE FOR THE TREATMENT OF BENIGN PROSTATIC LOWER URINARY TRACT SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA. A PHASE IV, RANDOMIZED, MULTICENTER, NON-INFERIORITY CLINICAL STUDY. SPRITE STUDY." Journal of Urology, vol. 197, no. 4, 2017, p. e100.